Item 2.02 Results of Operations and Financial Condition.

On July 30, 2020, Ultragenyx Pharmaceutical Inc. issued a press release announcing its financial results for the three months and six months ended June 30, 2020 (the "Press Release"). A copy of the Press Release is furnished herewith as Exhibit 99.1

The information set forth under Item 2.02 and in Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits



Exhibit No. Description
99.1          Press Release, dated July 30, 2020.
104         The cover page from the Company's Current Report on Form 8-K dated
            July 30, 2020 formatted in Inline XBRL.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses